The antibiotic efficacy of levofloxacin tablet was determined utilizing a verification method that included computational and experimental techniques. DFT, UV-VIS, and HPLC-20 AD
Abstract
- Levofloxacin is an antibiotic that is sold under the brand names Levaquin and others. It is used to treat a variety of bacterial diseases, including acute bacterial sinusitis, pneumonia, Helicobacter pylori (in conjunction with other drugs), urinary tract infections, chronic prostatitis, and certain types of gastroenteritis. It may be used in conjunction with other antibiotics to treat tuberculosis, meningitis, or pelvic inflammatory illness. Use is normally advised only when no other options are available. It is offered orally, intravenously, and as an eye drop. In this study, we are executing verification analysis to determine the efficacy of levofloxacin at several phases such as linearity, repeatability, precision, accuracy, and robustness to determine how stable our product is in these circumstances.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.